| Product Code: ETC9209794 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Gene Therapy Products Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Gene Therapy Products Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Gene Therapy Products Market - Industry Life Cycle |
3.4 Serbia Gene Therapy Products Market - Porter's Five Forces |
3.5 Serbia Gene Therapy Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Serbia Gene Therapy Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Gene Therapy Products Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Gene Therapy Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Serbia |
4.2.2 Rising demand for personalized medicine and targeted therapies |
4.2.3 Favorable government initiatives and regulations supporting gene therapy research and development |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy products |
4.3.2 Limited awareness and understanding of gene therapy among healthcare professionals and patients in Serbia |
4.3.3 Regulatory challenges and uncertainties surrounding gene therapy approvals in the country |
5 Serbia Gene Therapy Products Market Trends |
6 Serbia Gene Therapy Products Market, By Types |
6.1 Serbia Gene Therapy Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Serbia Gene Therapy Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Serbia Gene Therapy Products Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.1.4 Serbia Gene Therapy Products Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.1.5 Serbia Gene Therapy Products Market Revenues & Volume, By Luxturna, 2021- 2031F |
6.1.6 Serbia Gene Therapy Products Market Revenues & Volume, By Strimvelis, 2021- 2031F |
6.1.7 Serbia Gene Therapy Products Market Revenues & Volume, By Gendicine, 2021- 2031F |
6.2 Serbia Gene Therapy Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Gene Therapy Products Market Revenues & Volume, By Oncological Disorders, 2021- 2031F |
6.2.3 Serbia Gene Therapy Products Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.2.4 Serbia Gene Therapy Products Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Serbia Gene Therapy Products Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Serbia Gene Therapy Products Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.7 Serbia Gene Therapy Products Market Revenues & Volume, By Other Diseases, 2021- 2031F |
6.3 Serbia Gene Therapy Products Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Serbia Gene Therapy Products Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Serbia Gene Therapy Products Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.4 Serbia Gene Therapy Products Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 Serbia Gene Therapy Products Market Revenues & Volume, By Others, 2021- 2031F |
7 Serbia Gene Therapy Products Market Import-Export Trade Statistics |
7.1 Serbia Gene Therapy Products Market Export to Major Countries |
7.2 Serbia Gene Therapy Products Market Imports from Major Countries |
8 Serbia Gene Therapy Products Market Key Performance Indicators |
8.1 Number of clinical trials for gene therapy products conducted in Serbia |
8.2 Investment in gene therapy research and development in the country |
8.3 Number of partnerships and collaborations between local and international biotech companies for gene therapy projects |
9 Serbia Gene Therapy Products Market - Opportunity Assessment |
9.1 Serbia Gene Therapy Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Serbia Gene Therapy Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Gene Therapy Products Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Gene Therapy Products Market - Competitive Landscape |
10.1 Serbia Gene Therapy Products Market Revenue Share, By Companies, 2024 |
10.2 Serbia Gene Therapy Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here